Chair of DIA Council of Regulators Previews Risk Management & Drug Safety Updates

Chair of DIA’s Council of Regulators, Dr. Gerald Dal Pan has served since 2005 as Director of CDER’s Office of Surveillance and Epidemiology. A member of the World Health Organization Advisory Committee on the Safety of Medicinal Products, he has also served on working groups for the ICH and the Council of International Organizations of Medical Sciences, and will chair the FDA Update session at DIA’s annual Pharmacovigilance and Risk Management Strategies Conference 2017. In this exclusive podcast, Dr. Dal Pan discusses how big data impact evidence generation and drug safety, and previews these FDA Updates, including how the FDA Guidance on Best Practices for Pharmacoepidemiological Studies relates to postmarketing requirements. “We’re very pleased to be participating in DIA’s Pharmacovigilance and Risk Management Strategies Conference,” he explains. “My colleagues here at FDA and I have participated in it for many years.”